CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 8-K Event Bylaws or fiscal year change · Code of ethics change
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Insider Changes in Ownership
- EFFECT Other Notice of Effectiveness
- SC 13G Stake Amended Statement of Ownership
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- 4 Insider Changes in Ownership
Page 29 of 50 · 996 filings